These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22331365)

  • 1. Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.
    Miyake T; Kumagi T; Hirooka M; Koizumi M; Furukawa S; Ueda T; Tokumoto Y; Ikeda Y; Abe M; Kitai K; Hiasa Y; Matsuura B; Onji M
    J Gastroenterol; 2012 Jun; 47(6):696-703. PubMed ID: 22331365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
    Yoneda M; Imajo K; Eguchi Y; Fujii H; Sumida Y; Hyogo H; Ono M; Suzuki Y; Kawaguchi T; Aoki N; Sata M; Kanemasa K; Kohgo Y; Saibara T; Chayama K; Itoh Y; Yoshikawa T; Anzai K; Fujimoto K; Okanoue T; Nakajima A;
    J Gastroenterol; 2013 Sep; 48(9):1051-60. PubMed ID: 23184095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.
    Miyake T; Kumagi T; Hirooka M; Furukawa S; Koizumi M; Tokumoto Y; Ueda T; Yamamoto S; Abe M; Kitai K; Hiasa Y; Matsuura B; Onji M
    J Gastroenterol; 2013 Mar; 48(3):413-22. PubMed ID: 22933183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
    Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
    J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in asymptomatic obese women.
    Rodriguez-Hernandez H; Cervantes-Huerta M; Gonzalez JL; Marquez-Ramirez MD; Rodriguez-Moran M; Guerrero-Romero F
    Ann Hepatol; 2010; 9(2):144-9. PubMed ID: 20526006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
    Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
    Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.
    Molleston JP; Schwimmer JB; Yates KP; Murray KF; Cummings OW; Lavine JE; Brunt EM; Scheimann AO; Unalp-Arida A;
    J Pediatr; 2014 Apr; 164(4):707-713.e3. PubMed ID: 24360992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
    Martin-Rodriguez JL; Gonzalez-Cantero J; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
    Medicine (Baltimore); 2017 Apr; 96(17):e6770. PubMed ID: 28445310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
    Ybarra J; Fernández S; Sánchez-Hernández J; Romeo JH; Ballesta-Lopez C; Guell J; Mearin F
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):654-60. PubMed ID: 24667349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
    Amarapurkar DN; Patel ND
    Trop Gastroenterol; 2004; 25(3):130-4. PubMed ID: 15682660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease.
    Koga M; Saito H; Mukai M; Saibara T; Kasayama S
    Intern Med; 2011; 50(16):1657-61. PubMed ID: 21841322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.
    Bulum T; Kolarić B; Duvnjak L; Duvnjak M
    Dig Dis Sci; 2011 Dec; 56(12):3655-63. PubMed ID: 21735081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
    Kang Y; Park S; Kim S; Koh H
    BMC Pediatr; 2018 Jul; 18(1):215. PubMed ID: 29976192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018.
    Abrams GA; Rabil AM; Williams AP; Hecht EM
    Clin Pediatr (Phila); 2021 Jul; 60(8):370-375. PubMed ID: 34100658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups].
    Nah EH; Park JY
    Korean J Lab Med; 2008 Jun; 28(3):244-50. PubMed ID: 18594178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and metabolic determinants of abnormal alanine aminotransferase: A cross-sectional study of Iranian adults, 2018-2022.
    Asgari S; Molavizadeh D; Tohidi M; Momenan AA; Azizi F; Hadaegh F
    J Clin Lab Anal; 2023 Jun; 37(11-12):e24937. PubMed ID: 37403787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.